Master data| INID | Criterion | Field | Content | 
|---|
|  | Type of IP right | SART | Patent | 
|  | Status | ST | Pending/in force | 
| 21 | DE file number | DAKZ | 60 2021 038 731.8 | 
| 96 | EP file number | EAKZ | 21 71 6724.6 | 
| 86 | WO file number | WAKZ | PCT/EP2021/058727 | 
| 97 | EP publication number | EPN | 4188389 | 
| 87 | WO publication number | WPN | 2022022865 | 
| 54 | Designation/title | TI | DAPAGLIFLOZIN ZUR VERWENDUNG IN DER BEHANDLUNG VON CHRONISCHEN NIERENERKRANKUNGEN | 
| 51 | IPC main class | ICM (ICMV)
 | A61K 31/70 (2006.01) | 
| 51 | IPC secondary class(es) | ICS (ICSV)
 | A61P 31/12 (2006.01) | 
| 22 | DE application date | DAT | Apr 1, 2021 | 
| 96 | EP application date | EAT | Apr 1, 2021 | 
| 86 | WO application date | WAT | Apr 1, 2021 | 
| 43 | Date of first publication | OT | Feb 3, 2022 | 
|  | Date of publication of grant | PET | Sep 17, 2025 | 
| 71/73 | Applicant/owner | INH | Astrazeneca AB, Södertälje, SE | 
| 72 | Inventor | IN | LANGKILDE, Anna Maria, 151 85 Södertälje, SE | 
| 74 | Representative | VTR | Leinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE | 
|  | Address for service |  | Leinweber & Zimmermann Patentanwalts-PartG mbB, 80331 München, DE | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202063093961 P
 Oct 20, 2020
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202163161629 P
 Mar 16, 2021
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202063082524 P
 Sep 24, 2020
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202063070869 P
 Aug 27, 2020
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202063057139 P
 Jul 27, 2020
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202163152445 P
 Feb 23, 2021
 
 | 
| 33 31
 32
 
 | Foreign priority | PRC PRNA
 PRDA
 
 | US 202063119711 P
 Dec 1, 2020
 
 | 
|  | Due date | FT FG
 | Apr 30, 2026 Annual fee for the 6th year
Patent fees
 | 
|  | Patent division in charge |  | 44 | 
| 97 | EP language of publication | ELANG | EN - Englisch | 
| 84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | 
|  | Published EP/WO documents | EPWOPN | Original document: 
EP000004188389A1 Searchable text: 
EP000004188389A1
 Original document: 
EP000004188389B1
 Searchable text: 
EP000004188389B1
 Original document: 
WO002022022865
 Searchable text: 
WO002022022865
 | 
| 43 | Date of first publication | EVT | Feb 3, 2022 | 
|  | Date of the first transfer into DPMAregister | EREGT | Jun 7, 2023 | 
|  | Date of the (most recent) update in DPMAregister | REGT | Oct 9, 2025 (Show all update days)(Hide all update days)
 Oct 9, 2025St.36: changed (technical change)
Oct 2, 2025Procedures: Opposition procedure, Opposition filed, 17.09.2025: new
Sep 25, 2025St.36: changed (technical change)
Sep 20, 2025Representative: new
Address for service: changed
Procedures: Publications, DPMA mention of EP grant, 02.10.2025: new
Aug 28, 2025DE file number : new
DE application date: new
Date of publication of grant: new
Applicant/owner: new
Address for service: new
Due date: new
Published EP/WO documents: changed
File number displayed in the result list: changed
Procedures: Procedure relating to EP application, EPO publication of mention of grant , 17.09.2025: new
May 28, 2025Designation/title: changed
May 14, 2025St.36: changed (technical change)
Apr 2, 2025St.36: changed (technical change)
Jun 7, 2023
 Date of the first transfer into DPMAregister
 |